IGF1, insulin like growth factor 1, 3479

N. diseases: 1206; N. variants: 36
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.070 Biomarker phenotype BEFREE IGF-1 receptor (IGF1R) stimulation may promote malignant transformation promoting cell proliferation, dedifferentiation and inhibiting apoptosis. 27405474 2016
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.070 Biomarker phenotype BEFREE IGF-1 is a growth factor involved in cell proliferation, malignant transformation and inhibition of apoptosis. 27881235 2016
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.070 AlteredExpression phenotype BEFREE IGF1 and its receptor may be activated before carcinogenesis, and may promote the growth and malignant transformation of adenomatous polyps. 23801064 2013
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.070 Biomarker phenotype BEFREE Insulin-like growth factor-1 (IGF1) pathway plays a critical role in malignant transformation, and epidemiology studies have also shown that single nucleotide polymorphisms (SNPs) in IGF1 pathway genes are associated with prostate cancer risk. 23397154 2013
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.070 Biomarker phenotype BEFREE Thus, IGF-1R might be a factor in the morphological change of colorectal mucosal crypts, and it may play an important role in the growth and malignant transformation of precancerous polyps. 21728395 2011
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.070 Biomarker phenotype BEFREE The type 1 insulin-like growth factor receptor (IGF-IR) plays an important role in malignant transformation and in apoptosis. 10438568 1999
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.070 Biomarker phenotype BEFREE Our data suggest that IGF-I and its corresponding receptor may not be directly involved in endometrial cancer cell proliferation and differentiation in vivo, though other components of the IGF-I system (e.g., IGF binding proteins) may affect endometrial malignant transformation and tumor progression. 9935198 1999